Close Menu
September 11, 2020
Sponsored by
Deep Lens

Busting Cancer Patient Recruitment Bottlenecks In Precision Trials

Partner Webinar

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The interpretation of genomic test results is challenging for those untrained in this field. This results in lack of awareness for treating oncologists, overworked genetic counselors, and molecular team leads, which results in patients missing opportunities to be prescribed potentially life saving precision therapies. Using advanced ingestion tools and machine learning to automate patient identification and screening processes helps ensure patients do not miss the narrow windows for therapeutic decisions.

Learning Objectives

Sponsored by

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.